Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
86.26
-0.04 (-0.05%)
At close: Mar 20, 2026, 4:00 PM EDT
87.01
+0.75 (0.87%)
After-hours: Mar 20, 2026, 7:17 PM EDT

Globus Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,9392,5191,5681,023958.1
Revenue Growth (YoY)
16.65%60.62%53.34%6.76%21.43%
Cost of Revenue
957.81,035548.17263.73239.22
Gross Profit
1,9811,4841,020759.12718.88
Selling, General & Admin
1,178981.36643.84432.12408.15
Depreciation & Amortization Expenses
118.19119.3751.0317.7418.53
Research & Development
147.25163.75124.0173.0297.35
Other Operating Expenses
57.3853.468.278.322.91
Total Operating Expenses
1,5011,318887.16531.17546.93
Operating Income
479.82165.99133.14227.95171.95
Total Non-Operating Income (Expense)
125.25-45.2732.2515.078.45
Pretax Income
605.07120.72165.39243.02180.41
Provision for Income Taxes
67.217.7442.5252.8531.22
Net Income
537.87102.98122.87190.17149.19
Net Income to Common
537.87102.98122.87190.17149.19
Net Income Growth
422.28%-16.19%-35.39%27.47%45.86%
Shares Outstanding (Basic)
135136113100101
Shares Outstanding (Diluted)
137138115103104
Shares Change (YoY)
-0.58%20.27%11.68%-0.95%1.39%
EPS (Basic)
3.980.761.091.891.48
EPS (Diluted)
3.920.751.071.851.44
EPS Growth
422.67%-29.91%-42.16%28.47%8.27%
Free Cash Flow
588.77405.21165.23104.42219.38
Free Cash Flow Growth
45.30%145.25%58.23%-52.40%62.34%
Free Cash Flow Per Share
4.302.941.441.022.12
Gross Margin
67.41%58.90%65.05%74.22%75.03%
Operating Margin
16.33%6.59%8.49%22.29%17.95%
Profit Margin
18.30%4.09%7.83%18.59%15.57%
FCF Margin
20.03%16.08%10.53%10.21%22.90%
EBITDA
756.66419.38278.67296.2241.82
EBITDA Margin
25.75%16.65%17.77%28.96%25.24%
EBIT
479.82165.99133.14227.95171.95
EBIT Margin
16.33%6.59%8.49%22.29%17.95%
Effective Tax Rate
11.11%14.69%25.71%21.75%17.30%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q